In humans, deficiencies in RASGRP1 can result in a primary immunodeficiency (PID) syndrome, characterized by lymphopenia in CD4 + T cells and the development of Epstein-Barr virus (EBV)-associated B cell lymphoma [45]. This evidence concerns the gene CD4 and B-cell non-Hodgkin lymphoma.